Fingerprint
Dive into the research topics of 'Phase I trial of zoledronic acid + imatinib mesylate (Gleevec) in patients with bone metastases'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I trial of zoledronic acid + imatinib mesylate (Gleevec) in patients with bone metastases
Allan Lipton, Cynthia Campbell-Baird, Harold Harvey, Christian Kim, Laurence Demers, Luis Costa
Research output: Contribution to journal › Article › peer-review
10
Scopus
citations